Search

The integration of artificial intelligence (AI) into healthcare systems has revolutionized clinical analytics, enabling enhanced diagnostic accuracy, predictive modeling, and personalized treatment pathways. However, the opacity of many AI models poses significant challenges to their clinical adoption, necessitating advancements in explainable AI (XAI) to ensure interpretability and transparency. This narrative review synthesizes the literature on XAI within clinical systems, focusing on interpretability mechanisms, transparency frameworks, and deployment constraints in healthcare analytics. Drawing from high-impact studies, we examine how XAI addresses the “black box” nature of machine learning models in high-stakes medical decisions, particularly in contexts where performance has traditionally been prioritized over explainability. Key themes include the shift toward inherently interpretable models for critical applications, such as diagnostic imaging and predictive analytics, where post-hoc explanations often fall short. We explore the ethical imperatives for responsible AI deployment, including strategies for mitigating harm through transparent systems that align with clinical workflows. The review integrates perspectives on XAI in clinical diagnostics, emphasizing challenges in balancing model complexity with user trust. Transparency is framed not merely as a technical feature but as a systemic requirement, incorporating structured reporting practices for AI interventions and standardized modeling approaches. Deployment constraints are analyzed through the lens of real-world integration, including regulatory considerations, data privacy concerns, and human–AI interaction dynamics in healthcare infrastructures. We synthesize evidence from diverse applications, such as lung cancer diagnosis via explainable models and radiographic assessments, underscoring the need for multidisciplinary approaches to XAI. Furthermore, the review highlights biases in AI systems, particularly sex and gender disparities, and advocates for inclusive analytics to foster equitable healthcare. Clinical applications beyond the black box are discussed, with calls for standardized reporting to enhance reproducibility and trust. We position XAI as essential for closed-loop systems that incorporate feedback mechanisms, ensuring ongoing model recalibration in dynamic clinical environments. The synthesis reveals persistent gaps in current XAI deployments, such as overreliance on surrogate explanations that may mislead clinicians. Ultimately, this review proposes a systems-level framework for XAI in healthcare, integrating data ingestion, inference, decision support, and governance loops to overcome transparency barriers. This comprehensive overview informs the development of future AI-enabled healthcare infrastructures, emphasizing interpretability as a cornerstone for safe and effective clinical analytics.

The integration of multi-modal intelligence in healthcare represents a transformative paradigm, where artificial intelligence (AI) systems synthesize diverse clinical data streams—ranging from electronic health records (EHRs), imaging, genomics, and wearable sensor data—to enable more cohesive, predictive, and actionable insights. This narrative review synthesizes recent advancements in AI for healthcare systems and analytics, focusing on conceptual integration patterns that bridge disparate data modalities to enhance clinical decision-making and system-level efficiencies. We explore how multi-modal AI frameworks address the heterogeneity of healthcare data, fostering intelligent systems that support precision health, risk stratification, and closed-loop interventions. Key themes include the evolution of multi-modal machine learning techniques, such as fusion models that combine radiological imaging with clinical parameters for improved diagnostic accuracy, and the role of large language models (LLMs) in processing unstructured textual data alongside structured metrics. For instance, integrated frameworks leverage deep residual networks and transformers to handle multimodal inputs, enabling applications in areas like pulmonary hypertension prediction and Alzheimer’s disease progression forecasting. We highlight systems-level architectures that incorporate feedback loops for continuous model refinement, emphasizing the need for robust data modeling in federated learning environments to ensure privacy and interoperability across healthcare infrastructures. Challenges in data fusion, such as handling dataset shifts and ensuring equitable access to digital health tools, are contextualized within broader analytics pipelines. The review underscores original synthesis logic by framing integration patterns through a systems lens: data ingestion, intelligent inference, decision support, and governance. This approach reveals how multi-modal AI not only amplifies analytic capabilities but also redefines healthcare delivery models, from virtual biopsies using mammography data to comprehensive communication skills training for physicians via AI-driven video analysis. Ultimately, this synthesis positions multi-modal intelligence as a cornerstone for next-generation healthcare systems, promoting seamless interoperability and human-AI collaboration. By avoiding empirical benchmarks and focusing on conceptual patterns, we provide an interpretive framework that guides future deployments, ensuring AI enhances rather than disrupts clinical workflows.

The integration of artificial intelligence (AI) into healthcare systems has transformed population health analytics, enabling scalable infrastructures that process vast datasets to inform clinical decisions, resource allocation, and policy-making. This narrative review synthesizes recent literature on AI system architectures and governance models, focusing on how these elements underpin analytics-driven healthcare ecosystems. We examine the evolution of AI-enabled infrastructures, emphasizing federated learning, explainable models, and ethical frameworks to address data privacy, interoperability, and equity in population-level analytics. Key architectures include vertically integrated systems that streamline data ingestion, model deployment, and real-time inference, as seen in federated approaches that mitigate data silos while preserving patient confidentiality. Governance models are critical for ensuring trustworthy AI deployment, incorporating regulatory oversight, ethical principles adapted from military contexts to healthcare, and consensus-based guidelines for prediction models. We highlight the role of blockchain and data trusts in enhancing transparency and consent mechanisms, particularly in global health responses to pandemics and chronic disease management. The review structures the discourse around systems-level framing, integrating data flows, algorithmic decision support, and closed-loop feedback mechanisms that adapt to clinical outcomes. For instance, electronic health record (EHR)-based prediction models facilitate acute illness forecasting and outcome prediction in conditions like rheumatoid arthritis and oncology. We propose an original synthesis logic that conceptualizes AI infrastructures as adaptive networks, where governance acts as a regulatory layer overlaying architectural components to balance innovation with risk mitigation. Challenges such as bias in commercial datasets and the need for international cooperation are noted, but the emphasis remains on infrastructural resilience. Ultimately, this synthesis underscores the imperative for hybrid human-AI systems that prioritize population health equity, with governance models evolving to support sustainable analytics infrastructures. By positioning AI as a foundational tool for healthcare transformation, the review advocates for interdisciplinary collaboration to refine these systems, ensuring they deliver actionable insights while upholding ethical standards in diverse healthcare settings.

The integration of large language models (LLMs) into clinical healthcare systems represents a transformative shift in how data analytics, decision support, and operational infrastructure are conceptualized and deployed. This narrative review synthesizes recent advancements in LLMs within healthcare, focusing on their roles in enhancing clinical analytics, infrastructural frameworks, and oversight mechanisms while addressing inherent risk dynamics. Drawing from peer-reviewed literature, we examine how LLMs facilitate the processing of vast unstructured clinical data, such as electronic health records and patient narratives, to generate actionable insights that inform diagnostics, treatment planning, and resource allocation. Key infrastructural elements include scalable deployment pipelines that integrate LLMs with existing hospital information systems, enabling real-time analytics and predictive modeling without disrupting legacy workflows. Oversight is emphasized through regulatory frameworks that ensure ethical deployment, data privacy compliance, and bias mitigation, as LLMs amplify risks related to misinformation, algorithmic opacity, and equitable access in diverse clinical settings. Risk dynamics are explored in terms of model hallucinations, dependency on training data quality, and potential for exacerbating healthcare disparities if not properly governed. The review highlights systems-level analytics where LLMs contribute to closed-loop healthcare ecosystems, from data ingestion and inference to feedback-driven recalibration, fostering adaptive intelligence in clinical decision-making. For instance, LLMs have been adapted for tasks like text summarization, diagnostic reasoning, and patient communication, outperforming traditional methods in efficiency while requiring robust validation to maintain clinical fidelity. We underscore the need for interdisciplinary collaboration between clinicians, data scientists, and policymakers to harness LLMs' potential in optimizing healthcare delivery. By synthesizing cross-study evidence, this review proposes an original interpretive framework for LLM-enabled healthcare systems, structured around data-model-deployment-governance cycles, to guide future implementations. Ultimately, while LLMs promise enhanced analytics and infrastructural resilience, their clinical adoption demands vigilant oversight to balance innovation with patient safety and ethical integrity. This synthesis not only maps the current landscape but also identifies infrastructural gaps in scaling LLMs for equitable, high-stakes clinical environments, paving the way for more resilient healthcare analytics paradigms.

Generative artificial intelligence (GenAI) has emerged as a transformative force in healthcare systems, enabling advanced analytics, personalized interventions, and streamlined governance frameworks. This narrative review synthesizes recent literature on GenAI’s integration into healthcare infrastructures, emphasizing systems governance, safety protocols, and accountability mechanisms. We explore how GenAI enhances clinical decision-making, data analytics, and closed-loop systems while addressing ethical, regulatory, and operational challenges.At the core of healthcare systems, GenAI facilitates intelligent analytics by generating synthetic data for training models, simulating patient outcomes, and optimizing resource allocation. Governance frameworks are critical for ensuring responsible deployment, with studies highlighting the need for institutional guidelines that mitigate risks such as bias amplification and data privacy breaches. Safety considerations encompass algorithmic transparency, error detection in generative outputs, and human oversight in clinical loops. Accountability extends to lifecycle management, from model development to post-deployment monitoring, as evidenced by global initiatives and regional models like those in the GCC.The review delineates the landscape of GenAI applications in healthcare analytics, including predictive modeling for chronic disease management and real-time decision support. We propose an original systems-level framing that integrates data ingestion, inference generation, intervention deployment, and feedback recalibration under governance umbrellas. This synthesis reveals gaps in current infrastructures, such as the lack of standardized AI guardians for information overload and the challenges of scaling enterprise AI.In examining intelligent clinical decision systems, we highlight architectures that fuse GenAI with electronic health records (EHRs) for closed-loop operations, where generative models inform adaptive interventions. Ethical considerations are woven throughout, advocating for principles adapted from military contexts to healthcare. The adoption of GenAI in US hospitals underscores its potential for inpatient summaries and chronic care, yet calls for regulatory oversight to align with Helsinki declarations.Ultimately, this review positions GenAI as a cornerstone for accountable healthcare systems, urging interdisciplinary collaboration to balance innovation with safety. By synthesizing governance models, safety protocols, and accountability structures, we provide a roadmap for sustainable integration, fostering equitable health outcomes in an AI-augmented era.

The integration of artificial intelligence (AI) into healthcare systems and analytics represents a transformative shift toward more efficient, personalized, and predictive clinical practices. However, this evolution necessitates robust governance frameworks to ensure transparency, mitigate biases, and enable continuous lifecycle monitoring. This narrative review synthesizes recent literature on AI governance in healthcare, focusing on systems-level infrastructure and clinical analytics. Drawing from peer-reviewed publications, we examine how AI tools enhance healthcare delivery through data-driven insights while addressing ethical, regulatory, and operational challenges.Central to AI governance is transparency, which involves making algorithmic processes interpretable to clinicians and stakeholders. Studies highlight the need for explainable AI models in clinical decision-making, where opaque “black-box” systems can undermine trust and accountability. For instance, frameworks for implementing machine learning in healthcare emphasize ethical considerations, such as disclosing model limitations and decision rationales to prevent misinformed clinical actions. Bias mitigation emerges as a critical pillar, with research demonstrating how algorithmic biases in electronic health records can perpetuate health disparities, particularly among underrepresented populations. Strategies include proactive monitoring of algorithms for equity, incorporating diverse datasets during development, and post-deployment audits to detect and correct biases.Lifecycle monitoring models ensure sustained performance and safety of AI systems over time. This encompasses ongoing evaluation, recalibration, and governance structures that adapt to evolving clinical environments. Nationwide initiatives propose AI assurance laboratories to standardize monitoring, while institutional guidelines advocate for step-by-step implementation to avoid “AI winters” caused by unaddressed failures. In analytics contexts, large AI models facilitate health informatics by processing vast datasets for predictive analytics, yet they require governance to handle challenges like data privacy and model drift.The review structures its synthesis around healthcare systems’ end-to-end loops: from data ingestion to intelligent decision support and closed-loop interventions. It integrates cross-study analyses to propose original interpretive models for governance, emphasizing human-AI collaboration in clinical workflows. Key findings underscore the importance of multidisciplinary approaches, combining technical, ethical, and regulatory perspectives to foster responsible AI adoption. Ultimately, effective governance not only enhances patient outcomes but also builds public trust in AI-driven healthcare. This synthesis highlights gaps in current practices and advocates for integrative monitoring systems to realize AI’s full potential in equitable healthcare delivery.

Transformer-based architectures have significantly advanced clinical natural language processing by improving the capture of contextual relationships in unstructured electronic health records compared to earlier recurrent and convolutional models, with domain-specific variants such as ClinicalBERT and BioBERT designed to better handle clinical terminology, abbreviations, and specialized language, thereby improving information extraction performance, although the relative impact of different pre-training strategies remains insufficiently synthesized and requires systematic evaluation of corpus selection and fine-tuning approaches; this systematic review mapped studies focusing on pre-training corpora, fine-tuning methods, and named entity recognition performance across entity types such as medications, diseases, procedures, laboratory tests, and social determinants of health, using PRISMA-guided methods and searches across PubMed, ACL Anthology, arXiv, and IEEE Xplore, identifying 32 eligible studies from 1,247 records; findings showed that ClinicalBERT, BioBERT, and PubMedBERT were the most frequently evaluated models, pre-trained on datasets such as MIMIC-III, PubMed abstracts, and mixed biomedical corpora, with consistent evidence that domain-specific pre-training outperforms general-domain BERT models on benchmarks like i2b2 and n2c2 despite variation across entity types and fine-tuning strategies, while clinical pre-training on large EHR corpora improves named entity recognition and optimized fine-tuning approaches such as lower learning rates and data augmentation further enhance performance, particularly for medications and diseases, underscoring the importance of domain adaptation and the need for more standardized evaluation protocols in clinical NLP research.

Patient no-shows in outpatient clinics (5%–30% across specialties) disrupt scheduling efficiency, increase wait times, and strain healthcare resources. To address this, healthcare systems are increasingly applying machine learning (ML) for predictive scheduling support. This systematic review synthesizes ML approaches for predicting outpatient no-shows, focusing on model types, feature usage, and reported operational deployment outcomes, with emphasis on translation into clinical scheduling practice. A PRISMA-compliant search of PubMed, Embase, IEEE Xplore, Scopus, and Web of Science identified studies using ML for no-show prediction in outpatient settings. Data on models, features, performance, and implementation were extracted. Risk of bias was assessed using an adapted PROBAST tool. Thirty-two studies were included. Logistic regression, random forest, and XGBoost were the most commonly used models. Historical attendance data was the dominant predictive feature. Fewer than 20% of studies reported real-world implementation, and reported intervention outcomes (e.g., overbooking, reminders) were inconsistent. While ML models show strong predictive performance, real-world deployment and evidence of operational impact remain limited. This gap highlights the need to prioritize implementation-focused research to translate predictive accuracy into measurable improvements in clinic efficiency and access.

Alzheimer’s disease (AD) is the leading cause of dementia, affecting over 50 million people worldwide, with prevalence expected to triple by 2050. Early detection is crucial for clinical trial enrollment and care planning, and multimodal data (MRI, PET, CSF biomarkers, and cognitive assessments) provides complementary information on neurodegeneration, metabolism, and protein aggregation. This systematic review synthesizes AI/ML approaches for early AD detection using multimodal data, focusing on fusion strategies and performance across disease stages. Following PRISMA guidelines, searches of PubMed, IEEE Xplore, Scopus, Web of Science, and arXiv (2017–2023) identified studies using ML/DL with at least two modalities and reporting diagnostic performance. From 1,247 records, 35 studies were included. MRI was the most used modality (>90%), followed by cognitive tests (70–80%), PET (40–50%), and CSF (20–30%). Early fusion was most common, with increasing use of intermediate fusion. Multimodal models achieved AUROC of 0.90–0.98 for AD vs controls, but lower performance (0.70–0.85) for predicting MCI conversion to AD. Overall, multimodal AI improves early AD detection, with strong performance for diagnosis but persistent challenges in forecasting MCI progression due to heterogeneity and limited longitudinal data.

The integration of artificial intelligence into clinical decision support systems offers improved diagnostic accuracy and efficiency, but the opacity of many machine learning models raises concerns about trust, accountability, and regulatory compliance. Explainable artificial intelligence (XAI) has been proposed to address this by making model predictions interpretable to clinicians; however, its true clinical value remains uncertain, and evaluation has not kept pace with methodological development. This systematic review aimed to identify XAI methods used in clinical decision support systems, assess how they are evaluated with clinicians, and determine whether explanations improve diagnostic accuracy, trust, mental models, and efficiency. Following PRISMA guidelines, we searched PubMed, Web of Science, IEEE Xplore, ACM Digital Library, and Scopus for studies published between 2017 and 2024. Eligible studies included original research evaluating XAI in clinical decision support systems with clinician participants and reporting quantitative or qualitative outcomes. Risk of bias was assessed using adapted QUADAS-2 and ROBIS tools, and findings were synthesized narratively with subgroup analyses. From 2,847 records, 68 studies were included. The most common XAI methods were SHAP-based feature attribution (38%), saliency or heatmap methods (29%), concept-based approaches such as TCAV (15%), and counterfactual or example-based explanations (12%). Radiology was the dominant field (54%), followed by dermatology (18%) and pathology (12%). Evaluation approaches were highly inconsistent, with few validated instruments and most studies relying on Likert-scale trust measures or qualitative feedback. Only 16% of studies showed improved diagnostic accuracy with explanations, 67% showed no significant effect, and 17% reported reduced accuracy due to over-reliance or misinterpretation. Although 82% of studies reported increased clinician trust, trust rarely correlated with actual diagnostic performance. Overall, while XAI methods are widely studied in clinical decision support, their evaluation is inconsistent and their benefits are limited. Explanations tend to increase clinician trust without reliably improving diagnostic accuracy, and may sometimes worsen performance, highlighting a trust–accuracy gap that poses important safety concerns for clinical deployment.

Federated learning (FL) is promoted as a privacy-preserving method for training machine learning models across healthcare institutions without sharing patient data, with growing use in medical imaging, electronic health records, and rare disease research. This critical review examines FL studies from 2017–2024, focusing on privacy guarantees, statistical heterogeneity, communication efficiency, and real-world clinical deployment. A structured search of PubMed, IEEE Xplore, arXiv, and Google Scholar was conducted using relevant FL and healthcare terms, including studies addressing privacy, heterogeneity, communication, or deployment. Reported privacy guarantees are often overstated, with most studies relying on FedAvg without differential privacy. Statistical heterogeneity in non-IID settings remains largely unresolved. Fewer than 5% of studies report real-world deployment, typically at very small scale. A significant gap exists between FL research and clinical application. Current methods fall short of healthcare-grade privacy and real-world constraints, limiting readiness for high-stakes clinical use.

Postoperative complications including SSI (2–20%), VTE (1–5%), and respiratory failure (1–8%) significantly increase morbidity, mortality, length of stay, and readmissions. This systematic review assessed machine learning models predicting these outcomes, their performance, external validation, and clinical deployment. A PRISMA-based search (2017–2024) identified 32 eligible studies. Models such as random forest and XGBoost showed AUROC ranges of 0.70–0.85 for SSI, 0.75–0.90 for VTE (outperforming Caprini scores), and 0.75–0.88 for respiratory failure. However, fewer than 20% of studies included external validation and less than 5% reported clinical deployment. Overall, while machine learning models show strong retrospective performance, limited validation and minimal real-world implementation remain major barriers to clinical translation.

Suicidality and depression are major global health burdens, with over 700,000 suicide deaths annually and ~280 million people affected by major depressive disorder. Early risk prediction could support prevention, but traditional methods show limited accuracy. This PRISMA-compliant systematic review evaluated machine learning models for predicting suicidality and depression across electronic health records, social media, and wearable sensor data, focusing on performance, unimodal vs multimodal approaches, and ethical reporting. Searches of PubMed, PsycINFO, IEEE Xplore, arXiv, and ACM Digital Library identified eligible studies. EHR-based models showed AUROC 0.70–0.85 for suicide attempt prediction, social media models 0.70–0.80 for suicidal ideation, and wearable sensor models lower performance (0.65–0.75). Multimodal approaches improved performance by 5–10% over unimodal models. However, fewer than 20% of studies reported ethical considerations such as privacy, bias, or deployment safeguards. Overall, machine learning shows moderate-to-good predictive performance, with multimodal models performing best, but ethical reporting remains critically insufficient for clinical translation.